{
    "Watchman": [
        {
            "query": "What is the intended use for this device?",
            "answers": [
                {
                    "answer": "reduce the risk of stroke",
                    "type": "extractive",
                    "score": 0.8322796821594238,
                    "context": "o close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with ",
                    "offsets_in_document": [
                        {
                            "start": 638,
                            "end": 663
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "e9f0ff14146b628656fe6d33cecd71f8",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 14,
                        "page": 6,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "reduce the risk of stroke",
                    "type": "extractive",
                    "score": 0.7044291496276855,
                    "context": "o close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with ",
                    "offsets_in_document": [
                        {
                            "start": 369,
                            "end": 394
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "a3df60ddf2bfa0badaf97f73e47b9d89",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 4,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                },
                {
                    "answer": "reduce the risk of stroke",
                    "type": "extractive",
                    "score": 0.6800999641418457,
                    "context": "o close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with ",
                    "offsets_in_document": [
                        {
                            "start": 369,
                            "end": 394
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "438ddeafa3fc513634e5e251c81f204f",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 4,
                        "name": "WATCHMAN Procedure vs. Blood Thinners.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.6258454379501535,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "reduce the risk of stroke",
                    "type": "extractive",
                    "score": 0.5305920839309692,
                    "context": "AN and WATCHMAN FLX Devices are permanent implants designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke.",
                    "offsets_in_document": [
                        {
                            "start": 1130,
                            "end": 1155
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 124,
                            "end": 149
                        }
                    ],
                    "document_id": "331c892df748bd709f621cb521af8250",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 9,
                        "page": 4,
                        "name": "Alternative to Warfarin – WATCHMAN Implant.pdf"
                    }
                }
            ]
        },
        {
            "query": "What are contraindications for this device?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7230697662557724,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "anticoagulation",
                    "type": "extractive",
                    "score": 0.6416284441947937,
                    "context": "lation. This may Favor the Amulet for NVAF with contraindication to anticoagulation. The FDA in 2021 has approved the Amulet occluder for stroke preve",
                    "offsets_in_document": [
                        {
                            "start": 182,
                            "end": 197
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 68,
                            "end": 83
                        }
                    ],
                    "document_id": "61240259de465c85c6eacb3cdb1a8b65",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 21,
                        "page": 6,
                        "name": "anticoagulation.pdf"
                    }
                },
                {
                    "answer": "real or perceived risk of bleeding",
                    "type": "extractive",
                    "score": 0.6388237476348877,
                    "context": " because of absolute or relative contraindications due to real or perceived risk of bleeding. Although left atrial appendage closure is increasingly p",
                    "offsets_in_document": [
                        {
                            "start": 592,
                            "end": 626
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 58,
                            "end": 92
                        }
                    ],
                    "document_id": "59ad37fd36a378797ad7321a4f351e7",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 0,
                        "page": 1,
                        "name": "1-s2.0-S0002870317300881-main.pdf"
                    }
                },
                {
                    "answer": "absolute or relative",
                    "type": "extractive",
                    "score": 0.6156277060508728,
                    "context": "highest stroke risk.12 This is related to the presence of either absolute or relative contraindications to anticoagulation due to real or perceived ri",
                    "offsets_in_document": [
                        {
                            "start": 600,
                            "end": 620
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 65,
                            "end": 85
                        }
                    ],
                    "document_id": "2dfd0709052b1ace8533d7702d9cdba6",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 4,
                        "page": 1,
                        "name": "1-s2.0-S0002870317300881-main.pdf"
                    }
                },
                {
                    "answer": "absolute or relative contraindications due to real or perceived risk of bleeding",
                    "type": "extractive",
                    "score": 0.4399983882904053,
                    "context": "ver, they are underused because of absolute or relative contraindications due to real or perceived risk of bleeding. Although left atrial appendage cl",
                    "offsets_in_document": [
                        {
                            "start": 546,
                            "end": 626
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 35,
                            "end": 115
                        }
                    ],
                    "document_id": "59ad37fd36a378797ad7321a4f351e7",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 0,
                        "page": 1,
                        "name": "1-s2.0-S0002870317300881-main.pdf"
                    }
                }
            ]
        },
        {
            "query": "Who should not use this device?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.8009555808317891,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "patients",
                    "type": "extractive",
                    "score": 0.37306657433509827,
                    "context": "Third, our results should not be generalized to patients who have absolute contraindications to oral anticoagulant therapy. Last, the study sample siz",
                    "offsets_in_document": [
                        {
                            "start": 48,
                            "end": 56
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 48,
                            "end": 56
                        }
                    ],
                    "document_id": "115ca8a86fd1e8c00536e032f592aabd",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 43,
                        "page": 8,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                },
                {
                    "answer": "patients",
                    "type": "extractive",
                    "score": 0.285084068775177,
                    "context": "follow-up is complete. Third, our results should not be generalized to patients who have absolute contraindications to oral anticoagulant therapy. Las",
                    "offsets_in_document": [
                        {
                            "start": 927,
                            "end": 935
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 71,
                            "end": 79
                        }
                    ],
                    "document_id": "42f04adb54cc42b9f0caf9798aa00347",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 42,
                        "page": 8,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                },
                {
                    "answer": "patients with high bleeding risks",
                    "type": "extractive",
                    "score": 0.03726552426815033,
                    "context": ". The use of anticoagulants after WATCHMAN implantation in patients with high bleeding risks has been a source of debate. Objective: This article summ",
                    "offsets_in_document": [
                        {
                            "start": 270,
                            "end": 303
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 59,
                            "end": 92
                        }
                    ],
                    "document_id": "1a805861f6e576acb2a44ecb4efba316",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 1,
                        "page": 1,
                        "name": "anticoagulation.pdf"
                    }
                },
                {
                    "answer": "73%",
                    "type": "extractive",
                    "score": 0.036601997911930084,
                    "context": "lower use of anticoagulation compared with prior randomized controlled trials on WATCHMAN, as in this cohort 73% were deemed unsuitable to use (N)OAC.",
                    "offsets_in_document": [
                        {
                            "start": 1177,
                            "end": 1180
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 109,
                            "end": 112
                        }
                    ],
                    "document_id": "e65f788fdc1274ed39d98d58222986ce",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 56,
                        "page": 11,
                        "name": "CIRCEP.118.006841.pdf"
                    }
                }
            ]
        },
        {
            "query": "What are the dimensions of the device?",
            "answers": [
                {
                    "answer": "CardioKinetix",
                    "type": "extractive",
                    "score": 0.76308274269104,
                    "context": "m, Avinger, Bard, Boston Scientiﬁc, Bridgepoint, Cardiac Dimensions, CardioKinetix, CardioMEMS, Coherex, Contego, Covidien, CSI, CVRx, EndoCross, ev3,",
                    "offsets_in_document": [
                        {
                            "start": 482,
                            "end": 495
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 69,
                            "end": 82
                        }
                    ],
                    "document_id": "a15add2cfb6cc3a787d5c7a4b4cf815c",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 10,
                        "page": 2,
                        "name": "1-s2.0-S0735109714023419-main.pdf"
                    }
                },
                {
                    "answer": "about the size of a quarter",
                    "type": "extractive",
                    "score": 0.7432740330696106,
                    "context": "AN Implant? The WATCHMAN Implant is a small, flexible implant about the size of a quarter. It is made from very light, compact materials commonly used",
                    "offsets_in_document": [
                        {
                            "start": 301,
                            "end": 328
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 62,
                            "end": 89
                        }
                    ],
                    "document_id": "1135d98488e475ff1d491fe71445b1c8",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 4,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.6659657328788816,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "Cardiac Dimensions",
                    "type": "extractive",
                    "score": 0.4451335072517395,
                    "context": "bbott, Aptus, Atrium, Biosense Webster, Boston Scientific, Carag, Cardiac Dimensions, CardioKinetix, CardioMEMS, Cardiox, Celonova, CGuard, Coherex, C",
                    "offsets_in_document": [
                        {
                            "start": 324,
                            "end": 342
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 84
                        }
                    ],
                    "document_id": "2c13f77e0e79c869653844572f2c0007",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 60,
                        "page": 12,
                        "name": "CIRCEP.118.006841.pdf"
                    }
                },
                {
                    "answer": "Cardiac Dimensions",
                    "type": "extractive",
                    "score": 0.3099963665008545,
                    "context": "med, Aptus, Atrium, Avinger, Bard, Boston Scientiﬁc, Bridgepoint, Cardiac Dimensions, CardioKinetix, CardioMEMS, Coherex, Contego, Covidien, CSI, CVRx",
                    "offsets_in_document": [
                        {
                            "start": 462,
                            "end": 480
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 84
                        }
                    ],
                    "document_id": "a15add2cfb6cc3a787d5c7a4b4cf815c",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 10,
                        "page": 2,
                        "name": "1-s2.0-S0735109714023419-main.pdf"
                    }
                }
            ]
        },
        {
            "query": "What has this device been approved for?",
            "answers": [
                {
                    "answer": "stroke prevention",
                    "type": "extractive",
                    "score": 0.9760113954544067,
                    "context": " 1 endovascular device (Watchman) has been approved by the FDA for stroke prevention in this setting, which has been tested in 2 randomized studies an",
                    "offsets_in_document": [
                        {
                            "start": 682,
                            "end": 699
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 84
                        }
                    ],
                    "document_id": "d067a47c0d02dc80d8741ff8390b2a7f",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 30,
                        "page": 6,
                        "name": "1-s2.0-S0002870317300881-main.pdf"
                    }
                },
                {
                    "answer": "stroke prevention",
                    "type": "extractive",
                    "score": 0.8174728155136108,
                    "context": " for NVAF with contraindication to anticoagulation. The FDA in 2021 has approved the Amulet occluder for stroke prevention in patients with NVAF [29].",
                    "offsets_in_document": [
                        {
                            "start": 1101,
                            "end": 1118
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 105,
                            "end": 122
                        }
                    ],
                    "document_id": "e2099f1a558a06c8132921c8d5834a99",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 20,
                        "page": 6,
                        "name": "anticoagulation.pdf"
                    }
                },
                {
                    "answer": "stroke prevention in patients with NVAF",
                    "type": "extractive",
                    "score": 0.6893669366836548,
                    "context": "n. The FDA in 2021 has approved the Amulet occluder for stroke prevention in patients with NVAF [29]. Conclusion The best anticoagulant management fol",
                    "offsets_in_document": [
                        {
                            "start": 252,
                            "end": 291
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 56,
                            "end": 95
                        }
                    ],
                    "document_id": "61240259de465c85c6eacb3cdb1a8b65",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 21,
                        "page": 6,
                        "name": "anticoagulation.pdf"
                    }
                },
                {
                    "answer": "reducing the risk of stroke",
                    "type": "extractive",
                    "score": 0.6464553475379944,
                    "context": "d approved by the U.S. Food and Drug Administration (FDA) for reducing the risk of stroke in people with atrial fibrillation not caused by a heart val",
                    "offsets_in_document": [
                        {
                            "start": 256,
                            "end": 283
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 62,
                            "end": 89
                        }
                    ],
                    "document_id": "e241651c9adc81f2f3ef6c106a21e53e",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 5,
                        "page": 3,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                },
                {
                    "answer": "reducing the risk of stroke in people with atrial fibrillation not caused by a heart valve problem",
                    "type": "extractive",
                    "score": 0.6171041131019592,
                    "context": " Administration (FDA) for reducing the risk of stroke in people with atrial fibrillation not caused by a heart valve problem. More than 200,000 WATCHM",
                    "offsets_in_document": [
                        {
                            "start": 877,
                            "end": 975
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 26,
                            "end": 124
                        }
                    ],
                    "document_id": "1503a963da16708dc46f848f186eecde",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 4,
                        "page": 3,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                }
            ]
        },
        {
            "query": "Is the procedure minimally invasive?",
            "answers": [
                {
                    "answer": "minimally invasive",
                    "type": "extractive",
                    "score": 0.593614935874939,
                    "context": "The one-time, minimally invasive procedure for people with non-valvular AFib who need an alternative to blood thinners. ONE TIME. FOR A LIFETIME. WELC",
                    "offsets_in_document": [
                        {
                            "start": 14,
                            "end": 32
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 14,
                            "end": 32
                        }
                    ],
                    "document_id": "9e35ababdb14c8de0420cc0e7d6e3ca",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 0,
                        "page": 1,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "It is placed into your heart during a minimally invasive procedure and never needs to be replaced",
                    "type": "extractive",
                    "score": 0.5931258201599121,
                    "context": "ny other medical implants. It is placed into your heart during a minimally invasive procedure and never needs to be replaced. TAKING A CLOSER LOOK AT ",
                    "offsets_in_document": [
                        {
                            "start": 422,
                            "end": 519
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 27,
                            "end": 124
                        }
                    ],
                    "document_id": "1135d98488e475ff1d491fe71445b1c8",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 4,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.5552808155042624,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "minimally invasive therapeutic option",
                    "type": "extractive",
                    "score": 0.4913640022277832,
                    "context": "ter left atrial appendage (LAA) closure has emerged as a minimally invasive therapeutic option to prevent thrombus embolization from the LAA in patien",
                    "offsets_in_document": [
                        {
                            "start": 683,
                            "end": 720
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 57,
                            "end": 94
                        }
                    ],
                    "document_id": "64c8eefb42467db518b40f01a15ec144",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 3,
                        "page": 1,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                },
                {
                    "answer": "Transcatheter left atrial appendage (LAA) closure has emerged as a minimally invasive therapeutic option",
                    "type": "extractive",
                    "score": 0.4664035439491272,
                    "context": "GINAL RESEARCH ARTICLE Transcatheter left atrial appendage (LAA) closure has emerged as a minimally invasive therapeutic option to prevent thrombus em",
                    "offsets_in_document": [
                        {
                            "start": 616,
                            "end": 720
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 23,
                            "end": 127
                        }
                    ],
                    "document_id": "64c8eefb42467db518b40f01a15ec144",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 3,
                        "page": 1,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                }
            ]
        },
        {
            "query": "What anesthesia does the procedure require?",
            "answers": [
                {
                    "answer": "general",
                    "type": "extractive",
                    "score": 0.8151493072509766,
                    "context": " left atrial appendage (LAA) of your heart. The procedure is done under general anesthesia and takes as little as 30 minutes. Patients commonly stay i",
                    "offsets_in_document": [
                        {
                            "start": 125,
                            "end": 132
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 72,
                            "end": 79
                        }
                    ],
                    "document_id": "39af55dbfe289000f98172b3e0698908",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 3,
                        "page": 2,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                },
                {
                    "answer": "general",
                    "type": "extractive",
                    "score": 0.7309160232543945,
                    "context": "t through the tube, into your left atrial appendage (LAA). STEP 3 The procedure is typically done under general anesthesia and takes about 30 minutes.",
                    "offsets_in_document": [
                        {
                            "start": 1122,
                            "end": 1129
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 104,
                            "end": 111
                        }
                    ],
                    "document_id": "2c9dcf7e7850ad5cedecbf553a31278",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 9,
                        "page": 5,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7222103970318885,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "postimplant antithrombotic medication regimen, had a rationale for a nonpharmacological approach to stroke prevention, and had no other diagnoses that would require long-term anticoagulation",
                    "type": "extractive",
                    "score": 0.10753007233142853,
                    "context": "postimplant antithrombotic medication regimen, had a rationale for a nonpharmacological approach to stroke prevention, and had no other diagnoses that would require long-term anticoagulation",
                    "offsets_in_document": [
                        {
                            "start": 143,
                            "end": 333
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 190
                        }
                    ],
                    "document_id": "5f31c46a785d9219f866c1c8386f5ab1",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 6,
                        "page": 2,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                },
                {
                    "answer": "advance approval",
                    "type": "extractive",
                    "score": 0.0688864141702652,
                    "context": "ant is covered for eligible Medicare patients and does not require advance approval. If you have commercial insurance, you may need prior authorizatio",
                    "offsets_in_document": [
                        {
                            "start": 244,
                            "end": 260
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 83
                        }
                    ],
                    "document_id": "1b18981a0a682c9950bbf1fe724a20a6",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 8,
                        "page": 5,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                }
            ]
        },
        {
            "query": "When can patients stop taking blood thinners?",
            "answers": [
                {
                    "answer": "immediately after the procedure",
                    "type": "extractive",
                    "score": 0.8407865762710571,
                    "context": "IFF, 68 3\fWhile some people may be able stop blood thinners immediately after the procedure, in a clinical trial 96% of people were able to discontinu",
                    "offsets_in_document": [
                        {
                            "start": 418,
                            "end": 449
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 60,
                            "end": 91
                        }
                    ],
                    "document_id": "e5d9a97c0d552ce5cb2a96f2bdb2b3b5",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 1,
                        "page": 2,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "45 days after the WATCHMAN Implant procedure",
                    "type": "extractive",
                    "score": 0.720372200012207,
                    "context": " people were able to stop taking blood thinners just 45 days after the WATCHMAN Implant procedure. 3 The WATCHMAN Implant is placed into your heart in",
                    "offsets_in_document": [
                        {
                            "start": 552,
                            "end": 596
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 53,
                            "end": 97
                        }
                    ],
                    "document_id": "2b12f10ec41374bbf29348862e5849b7",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 2,
                        "page": 2,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.670180696998589,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "45 days after the WATCHMAN FLX procedure",
                    "type": "extractive",
                    "score": 0.5160408020019531,
                    "context": "of people were able to stop taking blood thinners just 45 days after the WATCHMAN FLX procedure. This can mean a lower risk of bleeding from long-term",
                    "offsets_in_document": [
                        {
                            "start": 661,
                            "end": 701
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 55,
                            "end": 95
                        }
                    ],
                    "document_id": "b01e661d7284077e7fabdd1a4a4e48b7",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 3,
                        "name": "Alternative to Warfarin – WATCHMAN Implant.pdf"
                    }
                },
                {
                    "answer": "After the Procedure 96% of patients were able to stop taking blood thinners just 45 days after the procedure",
                    "type": "extractive",
                    "score": 0.15033923089504242,
                    "context": "In a clinical trial: After the Procedure 96% of patients were able to stop taking blood thinners just 45 days after the procedure • 3 The WATCHMAN Imp",
                    "offsets_in_document": [
                        {
                            "start": 642,
                            "end": 750
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 21,
                            "end": 129
                        }
                    ],
                    "document_id": "1503a963da16708dc46f848f186eecde",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 4,
                        "page": 3,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                }
            ]
        },
        {
            "query": "When can patients stop taking anticoagulants?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.8753968800028498,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "immediately after the procedure",
                    "type": "extractive",
                    "score": 0.04136081039905548,
                    "context": "IFF, 68 3\fWhile some people may be able stop blood thinners immediately after the procedure, in a clinical trial 96% of people were able to discontinu",
                    "offsets_in_document": [
                        {
                            "start": 418,
                            "end": 449
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 60,
                            "end": 91
                        }
                    ],
                    "document_id": "e5d9a97c0d552ce5cb2a96f2bdb2b3b5",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 1,
                        "page": 2,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "45 days after the procedure",
                    "type": "extractive",
                    "score": 0.029591113328933716,
                    "context": " 96% of patients were able to stop taking blood thinners just 45 days after the procedure • 3 The WATCHMAN Implant is the most implanted device of its",
                    "offsets_in_document": [
                        {
                            "start": 102,
                            "end": 129
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 62,
                            "end": 89
                        }
                    ],
                    "document_id": "e241651c9adc81f2f3ef6c106a21e53e",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 5,
                        "page": 3,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                },
                {
                    "answer": "45 days after the WATCHMAN Implant procedure",
                    "type": "extractive",
                    "score": 0.01984899677336216,
                    "context": " people were able to stop taking blood thinners just 45 days after the WATCHMAN Implant procedure. 3 The WATCHMAN Implant is placed into your heart in",
                    "offsets_in_document": [
                        {
                            "start": 552,
                            "end": 596
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 53,
                            "end": 97
                        }
                    ],
                    "document_id": "2b12f10ec41374bbf29348862e5849b7",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 2,
                        "page": 2,
                        "name": "How The WATCHMAN Device Works.pdf"
                    }
                },
                {
                    "answer": "6 months",
                    "type": "extractive",
                    "score": 0.01334352046251297,
                    "context": "eir blood thinner, patients take aspirin and clopidogrel (Plavix®) for 6 months. After that, they take only aspirin on an ongoing basis. How Is WATCHM",
                    "offsets_in_document": [
                        {
                            "start": 885,
                            "end": 893
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 71,
                            "end": 79
                        }
                    ],
                    "document_id": "b01e661d7284077e7fabdd1a4a4e48b7",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 3,
                        "name": "Alternative to Warfarin – WATCHMAN Implant.pdf"
                    }
                }
            ]
        },
        {
            "query": "What is the success rate of the procedure?",
            "answers": [
                {
                    "answer": "95.1%",
                    "type": "extractive",
                    "score": 0.8258169889450073,
                    "context": " as device deployment and release, increased from 90.9% in PROTECT AF to 95.1% in PREVAIL (p ¼ 0.04). To evaluate the complications in PREVAIL by usin",
                    "offsets_in_document": [
                        {
                            "start": 757,
                            "end": 762
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 78
                        }
                    ],
                    "document_id": "c4dbdda8923dbf3a1d1acb27b5f3b286",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 34,
                        "page": 6,
                        "name": "1-s2.0-S0735109714023419-main.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.6372127240074549,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "95.1% in PREVA",
                    "type": "extractive",
                    "score": 0.6284705400466919,
                    "context": "evice deployment and release, increased from 90.9% in PROTECT AF to 95.1% in PREVAIL (p ¼ 0.04). To evaluate the complications in PREVAIL by using the",
                    "offsets_in_document": [
                        {
                            "start": 757,
                            "end": 771
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 68,
                            "end": 82
                        }
                    ],
                    "document_id": "c4dbdda8923dbf3a1d1acb27b5f3b286",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 34,
                        "page": 6,
                        "name": "1-s2.0-S0735109714023419-main.pdf"
                    }
                },
                {
                    "answer": "84",
                    "type": "extractive",
                    "score": 0.33890876173973083,
                    "context": " for the next week with a bit of limitation on strenuous activity. —SEAN, 84 DURING STEP 1 To begin the procedure, your doctor makes a small cut in yo",
                    "offsets_in_document": [
                        {
                            "start": 857,
                            "end": 859
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 74,
                            "end": 76
                        }
                    ],
                    "document_id": "2c9dcf7e7850ad5cedecbf553a31278",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 9,
                        "page": 5,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "favorable outcomes during 2-year follow-up",
                    "type": "extractive",
                    "score": 0.29775458574295044,
                    "context": "MAN left atrial appendage closure technology confirms favorable outcomes during 2-year follow-up in 1020 routine clinical practice patients, most of t",
                    "offsets_in_document": [
                        {
                            "start": 460,
                            "end": 502
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 54,
                            "end": 96
                        }
                    ],
                    "document_id": "ac43e48051bf79c6ffe2ee2812730dff",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 11,
                        "page": 2,
                        "name": "CIRCEP.118.006841.pdf"
                    }
                }
            ]
        },
        {
            "query": "What is the occurrence of pericardial effusions?",
            "answers": [
                {
                    "answer": "varies from 0.4% to 4%",
                    "type": "extractive",
                    "score": 0.5780178904533386,
                    "context": " studies, the incidence of early (<7 days) pericardial effusion varies from 0.4% to 4%,10,11 and in the National Cardiovascular Data Registry LAAO Reg",
                    "offsets_in_document": [
                        {
                            "start": 655,
                            "end": 677
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 64,
                            "end": 86
                        }
                    ],
                    "document_id": "a3195752040dadf1816e4b94d6dd3763",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 33,
                        "page": 7,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.5694975700002765,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "cardiac tamponade",
                    "type": "extractive",
                    "score": 0.4218093156814575,
                    "context": "s ﬁstula 1 0.4 Cardiac perforation 1 0.4 Pericardial effusion with cardiac tamponade 1 0.4 Major bleed requiring transfusion 1 0.4 Abbreviation as in ",
                    "offsets_in_document": [
                        {
                            "start": 811,
                            "end": 828
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 84
                        }
                    ],
                    "document_id": "93db3c73b6857c8e19646dd7db6a817c",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 37,
                        "page": 7,
                        "name": "1-s2.0-S0735109714023419-main.pdf"
                    }
                },
                {
                    "answer": "there were no pericardial effusions requiring drainage in the first 7 days",
                    "type": "extractive",
                    "score": 0.34319061040878296,
                    "context": "urred in 1.4%.4 In the present study, there were no pericardial effusions requiring drainage in the first 7 days. Between 7 and 45 days, 3 cases requi",
                    "offsets_in_document": [
                        {
                            "start": 914,
                            "end": 988
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 38,
                            "end": 112
                        }
                    ],
                    "document_id": "a3195752040dadf1816e4b94d6dd3763",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 33,
                        "page": 7,
                        "name": "CIRCULATIONAHA.120.050117.pdf"
                    }
                },
                {
                    "answer": "1.6% to 0.4%",
                    "type": "extractive",
                    "score": 0.3179510831832886,
                    "context": " Pericardial effusions requiring surgical repair also decreased from 1.6% to 0.4% (p ¼ 0.027); effusions requiring pericardiocentesis or a pericardial",
                    "offsets_in_document": [
                        {
                            "start": 488,
                            "end": 500
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 69,
                            "end": 81
                        }
                    ],
                    "document_id": "80fd050d1ef44f3a838d75db958759",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 35,
                        "page": 7,
                        "name": "1-s2.0-S0735109714023419-main.pdf"
                    }
                }
            ]
        },
        {
            "query": "Trying to get no answer",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7938485719300692,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "It's like having a big weight lifted off your shoulders",
                    "type": "extractive",
                    "score": 0.039230260998010635,
                    "context": "f his health. (Video length: 3:07) Tweet Email “It's like having a big weight lifted off your shoulders.” Share What’s the procedure like? Can you hav",
                    "offsets_in_document": [
                        {
                            "start": 691,
                            "end": 746
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 48,
                            "end": 103
                        }
                    ],
                    "document_id": "277a1c94b8ca8195c2ffa85ba5e4b22e",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 2,
                        "page": 2,
                        "name": "WATCHMAN Procedure vs. Blood Thinners.pdf"
                    }
                },
                {
                    "answer": "The WATCHMAN Implant is a small, flexible implant about the size of a quarter",
                    "type": "extractive",
                    "score": 0.028383713215589523,
                    "context": " (LAA) What is the WATCHMAN Implant? The WATCHMAN Implant is a small, flexible implant about the size of a quarter. It is made from very light, compac",
                    "offsets_in_document": [
                        {
                            "start": 251,
                            "end": 328
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 37,
                            "end": 114
                        }
                    ],
                    "document_id": "1135d98488e475ff1d491fe71445b1c8",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 7,
                        "page": 4,
                        "name": "WATCHMAN_DTP_Brochure.pdf"
                    }
                },
                {
                    "answer": "If You Struggle with Blood Thinners Answer a few short questions to see if you may be a candidate",
                    "type": "extractive",
                    "score": 0.024569876492023468,
                    "context": " Implant is right for you. If You Struggle with Blood Thinners Answer a few short questions to see if you may be a candidate and get a customized guid",
                    "offsets_in_document": [
                        {
                            "start": 244,
                            "end": 341
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 27,
                            "end": 124
                        }
                    ],
                    "document_id": "e802f4a22acd37b0552ec2c61fa6ebf2",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 4,
                        "page": 3,
                        "name": "WATCHMAN Procedure vs. Blood Thinners.pdf"
                    }
                },
                {
                    "answer": "Answer a few questions and get a customized guide Questions to Ask Your Doctor What are the risks and benefits of the different blood thinners",
                    "type": "extractive",
                    "score": 0.012902691960334778,
                    "context": "Answer a few questions and get a customized guide Questions to Ask Your Doctor What are the risks and benefits of the different blood thinners? • Does",
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 142
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 142
                        }
                    ],
                    "document_id": "331c892df748bd709f621cb521af8250",
                    "meta": {
                        "device": "Watchman",
                        "_split_id": 9,
                        "page": 4,
                        "name": "Alternative to Warfarin – WATCHMAN Implant.pdf"
                    }
                }
            ]
        }
    ],
    "Atriclip": [
        {
            "query": "What is the intended use for this device?",
            "answers": [
                {
                    "answer": "quick recovery and short hospital stay",
                    "type": "extractive",
                    "score": 0.7771782875061035,
                    "context": "ss than 1cm long. The design allows it to be introduced via keyhole on the left side of the chest allowing for quick recovery and short hospital stay.",
                    "offsets_in_document": [
                        {
                            "start": 1075,
                            "end": 1113
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 111,
                            "end": 149
                        }
                    ],
                    "document_id": "12e54160baaa7ede95111a64822ab1e0",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 5,
                        "page": 5,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "quick recovery and short hospital stay",
                    "type": "extractive",
                    "score": 0.7771782875061035,
                    "context": "ss than 1cm long. The design allows it to be introduced via keyhole on the left side of the chest allowing for quick recovery and short hospital stay.",
                    "offsets_in_document": [
                        {
                            "start": 1074,
                            "end": 1112
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 111,
                            "end": 149
                        }
                    ],
                    "document_id": "9fb61a67c6b26b7bf53ad44e75e6e360",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 5,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "surgical management of AF",
                    "type": "extractive",
                    "score": 0.7389947175979614,
                    "context": "y of evidence supporting the use of the AtriClip device in the surgical management of AF. On pooled analysis, thoracoscopic placement success rates we",
                    "offsets_in_document": [
                        {
                            "start": 405,
                            "end": 430
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "d1c7807c7801695e8652d7a323fa2a6c",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 25,
                        "page": 5,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "patients to exclude the LAA during concomitant cardiac surgery",
                    "type": "extractive",
                    "score": 0.7067875862121582,
                    "context": "short-term and has been approved for use in patients to exclude the LAA during concomitant cardiac surgery. This is the ﬁrst such device designed spec",
                    "offsets_in_document": [
                        {
                            "start": 361,
                            "end": 423
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 44,
                            "end": 106
                        }
                    ],
                    "document_id": "2832e726a2a9f8062b960d1ae3f5496",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 28,
                        "page": 6,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "stroke reduction",
                    "type": "extractive",
                    "score": 0.6841282248497009,
                    "context": "vice but with all the devices to see the clinical effectiveness of stroke reduction. Ailawadi et al Acquired Cardiovascular Disease The Journal of Tho",
                    "offsets_in_document": [
                        {
                            "start": 956,
                            "end": 972
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 83
                        }
                    ],
                    "document_id": "cff2451e5c4690fe93e981a2474f502c",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 46,
                        "page": 8,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                }
            ]
        },
        {
            "query": "What are contraindications for this device?",
            "answers": [
                {
                    "answer": "absolute contraindications to AC or abnormal LAA morphology",
                    "type": "extractive",
                    "score": 0.6915550827980042,
                    "context": "to achieve adequate protection. In this case, absolute contraindications to AC or abnormal LAA morphology both favor the Atriclip over a percutaneous ",
                    "offsets_in_document": [
                        {
                            "start": 817,
                            "end": 876
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 46,
                            "end": 105
                        }
                    ],
                    "document_id": "f2643731ea49bbed8eb708ef7b038a62",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 6,
                        "page": 2,
                        "name": "jafib-11-02087.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.6840277798060617,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "oral anticoagulants",
                    "type": "extractive",
                    "score": 0.6237003207206726,
                    "context": "ergoing cardiac surgery (with contraindications to treatment with oral anticoagulants) may represent a reasonable adjunct procedure to reduce the risk",
                    "offsets_in_document": [
                        {
                            "start": 1092,
                            "end": 1111
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 85
                        }
                    ],
                    "document_id": "3ddb6f3ed59d01512afda5de5e342385",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 4,
                        "page": 1,
                        "name": "eux211.pdf"
                    }
                },
                {
                    "answer": "long-term OAC (Class IIb)",
                    "type": "extractive",
                    "score": 0.5044412612915039,
                    "context": "ed in patients with high stroke risk and contraindications for long-term OAC (Class IIb)35; however, interestingly both criteria were not met in PROTE",
                    "offsets_in_document": [
                        {
                            "start": 877,
                            "end": 902
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "216626d4a38bac558964e2d37f43e396",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 36,
                        "page": 8,
                        "name": "eux211.pdf"
                    }
                },
                {
                    "answer": "absolute",
                    "type": "extractive",
                    "score": 0.4853655993938446,
                    "context": "ients who would benefit from AC (CHA2DS2-VASc score of 2 or more) have absolute contraindications for AC. A higher percentage may have relative contra",
                    "offsets_in_document": [
                        {
                            "start": 952,
                            "end": 960
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 71,
                            "end": 79
                        }
                    ],
                    "document_id": "fcf2422cd07fd14c1bdf12a5321c939b",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 4,
                        "page": 1,
                        "name": "jafib-11-02087.pdf"
                    }
                }
            ]
        },
        {
            "query": "Who should not use this device?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7919707681700695,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "blood thinners",
                    "type": "extractive",
                    "score": 0.15296101570129395,
                    "context": "e placed inside the heart this device does not require any need for blood thinners. However, Prof Weerasooriya will make the final recommendation depe",
                    "offsets_in_document": [
                        {
                            "start": 694,
                            "end": 708
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 68,
                            "end": 82
                        }
                    ],
                    "document_id": "7087dab985136a73607709367040803c",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 6,
                        "page": 6,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "Patients",
                    "type": "extractive",
                    "score": 0.14052915573120117,
                    "context": "your GP and also notify the cardiac surgeon. Taking showers with care. Patients must not go swimming or use a bathtub for 2-3 weeks until the wounds a",
                    "offsets_in_document": [
                        {
                            "start": 617,
                            "end": 625
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 71,
                            "end": 79
                        }
                    ],
                    "document_id": "92731df0ea254f7d6ca51d47f12a5197",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 11,
                        "page": 9,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "Patients",
                    "type": "extractive",
                    "score": 0.14052915573120117,
                    "context": "your GP and also notify the cardiac surgeon. Taking showers with care. Patients must not go swimming or use a bathtub for 2-3 weeks until the wounds a",
                    "offsets_in_document": [
                        {
                            "start": 617,
                            "end": 625
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 71,
                            "end": 79
                        }
                    ],
                    "document_id": "26f0b30122b310c78040bcddcf629446",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 11,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "patients without contraindications to anticoagulation",
                    "type": "extractive",
                    "score": 0.08124691992998123,
                    "context": "se patients were referred for LAA exclusion. For patients without contraindications to anticoagulation, the decision is less straight forward. The Zur",
                    "offsets_in_document": [
                        {
                            "start": 393,
                            "end": 446
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 49,
                            "end": 102
                        }
                    ],
                    "document_id": "78f396ea70b2a68970a07785f8f856b7",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 11,
                        "page": 3,
                        "name": "jafib-11-02087.pdf"
                    }
                }
            ]
        },
        {
            "query": "What are the dimensions of the device?",
            "answers": [
                {
                    "answer": "c o r e t v a s a 5 9 ( 2 0 1 7 ) e 3 7 6 – e 3 8 0 e378\fperhaps",
                    "type": "extractive",
                    "score": 0.7800856232643127,
                    "context": "dom from TIA/CVA during follow-up perriod. c o r e t v a s a 5 9 ( 2 0 1 7 ) e 3 7 6 – e 3 8 0 e378\fperhaps the most frequently implanted and clinical",
                    "offsets_in_document": [
                        {
                            "start": 319,
                            "end": 383
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 43,
                            "end": 107
                        }
                    ],
                    "document_id": "d7bd0d1d89e0d8dff3ee53e53173aed0",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 13,
                        "page": 3,
                        "name": "1-s2.0-S0010865017300772-main.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7496449795990017,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "t v a s a 5 9 ( 2 0 1 7 ) e 3 7 6 – e 3 8 0 e378\fperhaps",
                    "type": "extractive",
                    "score": 0.7474217414855957,
                    "context": "from TIA/CVA during follow-up perriod. c o r e t v a s a 5 9 ( 2 0 1 7 ) e 3 7 6 – e 3 8 0 e378\fperhaps the most frequently implanted and clinically t",
                    "offsets_in_document": [
                        {
                            "start": 327,
                            "end": 383
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 47,
                            "end": 103
                        }
                    ],
                    "document_id": "d7bd0d1d89e0d8dff3ee53e53173aed0",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 13,
                        "page": 3,
                        "name": "1-s2.0-S0010865017300772-main.pdf"
                    }
                },
                {
                    "answer": "below 5 mm",
                    "type": "extractive",
                    "score": 0.4616297483444214,
                    "context": " if residual peri-device ﬂow (endoleak) existed but the jet width was below 5 mm, what could be prothrombogenic issue in patients' future life. In the",
                    "offsets_in_document": [
                        {
                            "start": 116,
                            "end": 126
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 70,
                            "end": 80
                        }
                    ],
                    "document_id": "65ede36388556cf669ee02541513d443",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 14,
                        "page": 4,
                        "name": "1-s2.0-S0010865017300772-main.pdf"
                    }
                },
                {
                    "answer": "1cm",
                    "type": "extractive",
                    "score": 0.37222427129745483,
                    "context": "is is a brief procedure involving three small keyhole incisions less than 1cm long. The design allows it to be introduced via keyhole on the left side",
                    "offsets_in_document": [
                        {
                            "start": 972,
                            "end": 975
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 74,
                            "end": 77
                        }
                    ],
                    "document_id": "12e54160baaa7ede95111a64822ab1e0",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 5,
                        "page": 5,
                        "name": "Booklet-AtriClip.pdf"
                    }
                }
            ]
        },
        {
            "query": "What has this device been approved for?",
            "answers": [
                {
                    "answer": "use in patients to exclude the LAA during concomitant cardiac surgery",
                    "type": "extractive",
                    "score": 0.7460586428642273,
                    "context": "the short-term and has been approved for use in patients to exclude the LAA during concomitant cardiac surgery. This is the ﬁrst such device designed ",
                    "offsets_in_document": [
                        {
                            "start": 354,
                            "end": 423
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 41,
                            "end": 110
                        }
                    ],
                    "document_id": "2832e726a2a9f8062b960d1ae3f5496",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 28,
                        "page": 6,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "to exclude the LAA in patients with AF undergoing cardiac surgery",
                    "type": "extractive",
                    "score": 0.6704529523849487,
                    "context": "on (US-FDA) and is increasingly being used to exclude the LAA in patients with AF undergoing cardiac surgery. The AtriClipTM device (AtriClip Pro, Atr",
                    "offsets_in_document": [
                        {
                            "start": 849,
                            "end": 914
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 43,
                            "end": 108
                        }
                    ],
                    "document_id": "86e00eb92bb4a010c1f17cc1d46b4878",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 4,
                        "page": 2,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "open sternotomy, and the other is used for thoracoscopic approach",
                    "type": "extractive",
                    "score": 0.5607214570045471,
                    "context": "oved deployment tools. One is designed for open sternotomy, and the other is used for thoracoscopic approach. Both are smaller and more ﬂexible, and h",
                    "offsets_in_document": [
                        {
                            "start": 552,
                            "end": 617
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 43,
                            "end": 108
                        }
                    ],
                    "document_id": "4bb889aa9576ea8c7a4f6f3bdb8e2d01",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 37,
                        "page": 7,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "FDA",
                    "type": "extractive",
                    "score": 0.5451006889343262,
                    "context": " then reattach it to the deployment tool and put it on again. The current FDA-approved device has a mechanism to open and close, and once you are happ",
                    "offsets_in_document": [
                        {
                            "start": 180,
                            "end": 183
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 74,
                            "end": 77
                        }
                    ],
                    "document_id": "7781faeddefc7317005065ca5fefa86d",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 45,
                        "page": 8,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "open-heart surgery",
                    "type": "extractive",
                    "score": 0.5432895421981812,
                    "context": "ity of concomitant device-enabled epicardial LAA occlusion during open-heart surgery. In addition to long-term follow-up, we evaluate the impact on st",
                    "offsets_in_document": [
                        {
                            "start": 108,
                            "end": 126
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 84
                        }
                    ],
                    "document_id": "a70f8a39ddd697cd3087d5231a03665a",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 3,
                        "page": 1,
                        "name": "eux211.pdf"
                    }
                }
            ]
        },
        {
            "query": "Is the procedure minimally invasive?",
            "answers": [
                {
                    "answer": "minimally invasive approaches",
                    "type": "extractive",
                    "score": 0.7421174049377441,
                    "context": "trial appendage exclusion for prevention of stroke in atrial fibrillation: review of minimally invasive approaches. Curr Cardiol Rep 2014;16:1–10. 30.",
                    "offsets_in_document": [
                        {
                            "start": 1156,
                            "end": 1185
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 85,
                            "end": 114
                        }
                    ],
                    "document_id": "72e298059be19db19401ebda75727be4",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 48,
                        "page": 10,
                        "name": "eux211.pdf"
                    }
                },
                {
                    "answer": "minimally invasive",
                    "type": "extractive",
                    "score": 0.7374721169471741,
                    "context": "lmes SD. New approach to exclude the left atrial appendage during minimally invasive cryothermic surgical ablation. Innovations 2015;10:323–7. [25] Ak",
                    "offsets_in_document": [
                        {
                            "start": 1075,
                            "end": 1093
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 84
                        }
                    ],
                    "document_id": "d7a0b21218bdabbc73c9ee0dd16815e4",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 40,
                        "page": 8,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "minimally invasive",
                    "type": "extractive",
                    "score": 0.6536215543746948,
                    "context": " of the Atriclip left atrial appendage exclusion device placed by minimally invasive thoracoscopic approach. JACC Clin Electrophysiol 2017;3:1356–65. ",
                    "offsets_in_document": [
                        {
                            "start": 606,
                            "end": 624
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 84
                        }
                    ],
                    "document_id": "d7a0b21218bdabbc73c9ee0dd16815e4",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 40,
                        "page": 8,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "minimally invasive cryothermic surgical ablation",
                    "type": "extractive",
                    "score": 0.5957198143005371,
                    "context": "proach to exclude the left atrial appendage during minimally invasive cryothermic surgical ablation. Innovations 2015;10:323–7. [25] Akca F, Verberkmo",
                    "offsets_in_document": [
                        {
                            "start": 57,
                            "end": 105
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 51,
                            "end": 99
                        }
                    ],
                    "document_id": "37026acb92052032f6788d952ff805bc",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 41,
                        "page": 8,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "minimally invasive mitral valve surgery: technically feasible and safe",
                    "type": "extractive",
                    "score": 0.5907760858535767,
                    "context": "t left atrial appendage clipping during minimally invasive mitral valve surgery: technically feasible and safe. J Atr Fibrillation 2016;9:1407. [28] S",
                    "offsets_in_document": [
                        {
                            "start": 811,
                            "end": 881
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 40,
                            "end": 110
                        }
                    ],
                    "document_id": "37026acb92052032f6788d952ff805bc",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 41,
                        "page": 8,
                        "name": "ivz156.pdf"
                    }
                }
            ]
        },
        {
            "query": "What anesthesia does the procedure require?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7518288531713357,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "Types of stroke",
                    "type": "extractive",
                    "score": 0.16308295726776123,
                    "context": "..................................................................4 Types of stroke...................................................................",
                    "offsets_in_document": [
                        {
                            "start": 427,
                            "end": 442
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 68,
                            "end": 83
                        }
                    ],
                    "document_id": "bb2f27ada03f992e4cc85b95a50cba3b",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 0,
                        "page": 1,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "oral anticoagulants",
                    "type": "extractive",
                    "score": 0.14274868369102478,
                    "context": "ergoing cardiac surgery (with contraindications to treatment with oral anticoagulants) may represent a reasonable adjunct procedure to reduce the risk",
                    "offsets_in_document": [
                        {
                            "start": 1092,
                            "end": 1111
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 85
                        }
                    ],
                    "document_id": "3ddb6f3ed59d01512afda5de5e342385",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 4,
                        "page": 1,
                        "name": "eux211.pdf"
                    }
                },
                {
                    "answer": "a large trial of at least 2000 patients",
                    "type": "extractive",
                    "score": 0.100458525121212,
                    "context": " the million dollar question. I suspect it will require a large trial of at least 2000 patients. We will need to see what type of funding is available",
                    "offsets_in_document": [
                        {
                            "start": 703,
                            "end": 742
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 56,
                            "end": 95
                        }
                    ],
                    "document_id": "cff2451e5c4690fe93e981a2474f502c",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 46,
                        "page": 8,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "7",
                    "type": "extractive",
                    "score": 0.09988024830818176,
                    "context": "e..........................................................................7 After the procedure......................................................",
                    "offsets_in_document": [
                        {
                            "start": 1280,
                            "end": 1281
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 75,
                            "end": 76
                        }
                    ],
                    "document_id": "bb2f27ada03f992e4cc85b95a50cba3b",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 0,
                        "page": 1,
                        "name": "Booklet-AtriClip.pdf"
                    }
                }
            ]
        },
        {
            "query": "When can patients stop taking blood thinners?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.8157832556563661,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "If a patient does not tolerate a blood thinner",
                    "type": "extractive",
                    "score": 0.06725573539733887,
                    "context": "atments have been developed to help these patients. If a patient does not tolerate a blood thinner then a specialist may recommend left atrial appenda",
                    "offsets_in_document": [
                        {
                            "start": 275,
                            "end": 321
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 52,
                            "end": 98
                        }
                    ],
                    "document_id": "12e54160baaa7ede95111a64822ab1e0",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 5,
                        "page": 5,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "If a patient does not tolerate a blood thinner",
                    "type": "extractive",
                    "score": 0.06725573539733887,
                    "context": "atments have been developed to help these patients. If a patient does not tolerate a blood thinner then a specialist may recommend left atrial appenda",
                    "offsets_in_document": [
                        {
                            "start": 275,
                            "end": 321
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 52,
                            "end": 98
                        }
                    ],
                    "document_id": "9fb61a67c6b26b7bf53ad44e75e6e360",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 5,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "After surgery",
                    "type": "extractive",
                    "score": 0.019407156854867935,
                    "context": "e TOE to assess and confirm the absence of any before the procedure. After surgery, you will be commenced on blood thinners to prevent clot formation ",
                    "offsets_in_document": [
                        {
                            "start": 99,
                            "end": 112
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 69,
                            "end": 82
                        }
                    ],
                    "document_id": "9f44ed206198862264a1e25603efdd11",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 13,
                        "page": 10,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "After surgery",
                    "type": "extractive",
                    "score": 0.019407156854867935,
                    "context": "e TOE to assess and confirm the absence of any before the procedure. After surgery, you will be commenced on blood thinners to prevent clot formation ",
                    "offsets_in_document": [
                        {
                            "start": 99,
                            "end": 112
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 69,
                            "end": 82
                        }
                    ],
                    "document_id": "4838d6e68c5c555d72ce30acf4d79216",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 13,
                        "name": "Booklet-AtriClip.pdf"
                    }
                }
            ]
        },
        {
            "query": "When can patients stop taking anticoagulants?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.8144867883524938,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "Not using ointments or creams on the wounds. If you have any unusual pain or redness, please visit your GP and also notify the cardiac surgeon. Taking showers with care. Patients must not go swimming or use a bathtub for 2-3 weeks until the wounds are completely healed",
                    "type": "extractive",
                    "score": 0.017835374921560287,
                    "context": " Not using ointments or creams on the wounds. If you have any unusual pain or redness, please visit your GP and also notify the cardiac surgeon. Taking showers with care. Patients must not go swimming or use a bathtub for 2-3 weeks until the wounds are completely healed",
                    "offsets_in_document": [
                        {
                            "start": 447,
                            "end": 716
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 1,
                            "end": 270
                        }
                    ],
                    "document_id": "92731df0ea254f7d6ca51d47f12a5197",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 11,
                        "page": 9,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "Not using ointments or creams on the wounds. If you have any unusual pain or redness, please visit your GP and also notify the cardiac surgeon. Taking showers with care. Patients must not go swimming or use a bathtub for 2-3 weeks until the wounds are completely healed",
                    "type": "extractive",
                    "score": 0.017835374921560287,
                    "context": " Not using ointments or creams on the wounds. If you have any unusual pain or redness, please visit your GP and also notify the cardiac surgeon. Taking showers with care. Patients must not go swimming or use a bathtub for 2-3 weeks until the wounds are completely healed",
                    "offsets_in_document": [
                        {
                            "start": 447,
                            "end": 716
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 1,
                            "end": 270
                        }
                    ],
                    "document_id": "26f0b30122b310c78040bcddcf629446",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 11,
                        "name": "Booklet-AtriClip.pdf"
                    }
                },
                {
                    "answer": "preoperatively",
                    "type": "extractive",
                    "score": 0.0071675339713692665,
                    "context": "these, 51.2% of patients were in sinus-rhythm when admitted and 67.4% of patients were on treatment with oral anticoagulants preoperatively (Table 1).",
                    "offsets_in_document": [
                        {
                            "start": 1196,
                            "end": 1210
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 125,
                            "end": 139
                        }
                    ],
                    "document_id": "e7cc6c0253f9ecf771084265688b9f50",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 19,
                        "page": 4,
                        "name": "eux211.pdf"
                    }
                },
                {
                    "answer": "Apr - May 2019",
                    "type": "extractive",
                    "score": 0.0026386422105133533,
                    "context": "cant risk of bleeding from anticoagulation persists. \fwww.jafib.com Apr - May 2019 | Volume-11 | Issue-6 Featured Review Journal of Atrial Fibrillatio",
                    "offsets_in_document": [
                        {
                            "start": 484,
                            "end": 498
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 68,
                            "end": 82
                        }
                    ],
                    "document_id": "7705e94a62494865acec9e7165919709",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 5,
                        "page": 1,
                        "name": "jafib-11-02087.pdf"
                    }
                }
            ]
        },
        {
            "query": "What is the success rate of the procedure?",
            "answers": [
                {
                    "answer": "98%",
                    "type": "extractive",
                    "score": 0.8697187304496765,
                    "context": "idual stump smaller than 1 cm. The periprocedural success was achieved in 98% of the patients. Three patients who did not meet this criterion had resi",
                    "offsets_in_document": [
                        {
                            "start": 559,
                            "end": 562
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 74,
                            "end": 77
                        }
                    ],
                    "document_id": "88cf178828e1e533d1456126c1886465",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 6,
                        "page": 2,
                        "name": "1-s2.0-S0010865017300772-main.pdf"
                    }
                },
                {
                    "answer": "95.3%",
                    "type": "extractive",
                    "score": 0.8385487794876099,
                    "context": "nt of AF. On pooled analysis, thoracoscopic placement success rates were 95.3% compared to 99.2% for patients in whom clips were placed via an open te",
                    "offsets_in_document": [
                        {
                            "start": 495,
                            "end": 500
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 78
                        }
                    ],
                    "document_id": "d1c7807c7801695e8652d7a323fa2a6c",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 25,
                        "page": 5,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "greater than 95%",
                    "type": "extractive",
                    "score": 0.6189560294151306,
                    "context": ". The Bayesian posterior probability of LAA exclusion success rate greater than 95% and Bayesian posterior probability of serious device-related AE ra",
                    "offsets_in_document": [
                        {
                            "start": 1275,
                            "end": 1291
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 83
                        }
                    ],
                    "document_id": "3abcf31d3c30d5646eafc5f463341c4a",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 15,
                        "page": 2,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.5971621629402032,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "greater than 95%",
                    "type": "extractive",
                    "score": 0.5236911177635193,
                    "context": ". The Bayesian posterior probability of LAA exclusion success rate greater than 95% and Bayesian posterior probability of serious device-related AE ra",
                    "offsets_in_document": [
                        {
                            "start": 1275,
                            "end": 1291
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 83
                        }
                    ],
                    "document_id": "d04f1a1eadadd6ec3a742a43733ed251",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 16,
                        "page": 2,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                }
            ]
        },
        {
            "query": "What is the occurrence of pericardial effusions?",
            "answers": [
                {
                    "answer": "less common",
                    "type": "extractive",
                    "score": 0.7738432884216309,
                    "context": " pericarditis may be another cause of pericardial effusions, although less common. In canine models, the AtriClip has been shown to be completely iner",
                    "offsets_in_document": [
                        {
                            "start": 305,
                            "end": 316
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 70,
                            "end": 81
                        }
                    ],
                    "document_id": "a1e6b928891a54878e7a2d830f4ef48d",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 15,
                        "page": 3,
                        "name": "jafib-11-02087.pdf"
                    }
                },
                {
                    "answer": "rarely of clinical consequences",
                    "type": "extractive",
                    "score": 0.762372612953186,
                    "context": "effusions in approximately one percent of patients, that is rarely of clinical consequences. [12,13] Other epicardial devices reported a pericardial e",
                    "offsets_in_document": [
                        {
                            "start": 583,
                            "end": 614
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 60,
                            "end": 91
                        }
                    ],
                    "document_id": "a570875b9f69bda45e23480e18ef566f",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 14,
                        "page": 3,
                        "name": "jafib-11-02087.pdf"
                    }
                },
                {
                    "answer": "Volume overload",
                    "type": "extractive",
                    "score": 0.722756564617157,
                    "context": "se events. Adverse event Etiology Management Pericardial effusion - Volume overload, partly related to sudden decrease in ANP - Pericarditis (rare aft",
                    "offsets_in_document": [
                        {
                            "start": 380,
                            "end": 395
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 68,
                            "end": 83
                        }
                    ],
                    "document_id": "91ccee5720004f232a15732364c5ed0d",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 13,
                        "page": 3,
                        "name": "jafib-11-02087.pdf"
                    }
                },
                {
                    "answer": "with or without pericarditis",
                    "type": "extractive",
                    "score": 0.6544917821884155,
                    "context": "ip experiences. Adverse events include pericardial effusions with or without pericarditis, tachyarrhythmias and respiratory dysfunction mostly related",
                    "offsets_in_document": [
                        {
                            "start": 892,
                            "end": 920
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 61,
                            "end": 89
                        }
                    ],
                    "document_id": "d5755fb23fd4c26c6be05feb5eec64fc",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 8,
                        "page": 2,
                        "name": "jafib-11-02087.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.5855286201079664,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                }
            ]
        },
        {
            "query": "Trying to get no answer",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.6477343265548238,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "No No No No No No No No No No No 6",
                    "type": "extractive",
                    "score": 0.4172442555427551,
                    "context": "r description, or variance and effect estimates provided? No No No No No No No No No No No 6. Were the exposure(s) of interest measured prior to the o",
                    "offsets_in_document": [
                        {
                            "start": 537,
                            "end": 571
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 58,
                            "end": 92
                        }
                    ],
                    "document_id": "d088a526c1849c031eff9bb5590d8181",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 14,
                        "page": 4,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "No No No No No No No No No No No 13",
                    "type": "extractive",
                    "score": 0.15209650993347168,
                    "context": "assessors blinded to the exposure status of participants? No No No No No No No No No No No 13. Was loss to follow-up after baseline 20% or less? Yes Y",
                    "offsets_in_document": [
                        {
                            "start": 664,
                            "end": 699
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 58,
                            "end": 93
                        }
                    ],
                    "document_id": "460bba0e5e3ca7a82ba4d9a6208700d4",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 15,
                        "page": 4,
                        "name": "ivz156.pdf"
                    }
                },
                {
                    "answer": "LAA is not appropriate for exclusion based on intraoperative evaluations",
                    "type": "extractive",
                    "score": 0.10742822289466858,
                    "context": "LAA is not appropriate for exclusion based on intraoperative evaluations. 8. Current diagnosis of active systemic infection 9. Renal failure requiring",
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 72
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 72
                        }
                    ],
                    "document_id": "180761b3d13bb740033b1b1d955a746d",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 49,
                        "page": 9,
                        "name": "1-s2.0-S0022522311008282-main.pdf"
                    }
                },
                {
                    "answer": "surgery 7 0 No ﬂow to LAA",
                    "type": "extractive",
                    "score": 0.09750398248434067,
                    "context": " 0 0 0 Suwalski et al. [26] 7 Median sternotomy, other cardiac surgery 7 0 No ﬂow to LAA, residual stump <10 mm 0 0 0 0 0 0 Akca et al. [27] 5 Thoraco",
                    "offsets_in_document": [
                        {
                            "start": 387,
                            "end": 412
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "e19d3a7ce0c7441a74fd0916efaf4344",
                    "meta": {
                        "device": "Atriclip",
                        "_split_id": 24,
                        "page": 5,
                        "name": "ivz156.pdf"
                    }
                }
            ]
        }
    ],
    "Lariat": [
        {
            "query": "What is the intended use for this device?",
            "answers": [
                {
                    "answer": "LAA exclusion",
                    "type": "extractive",
                    "score": 0.920237123966217,
                    "context": " risks of adverse events with off-label use of the Lariat device for LAA exclusion. Formal, controlled investigations into the safety and efficacy of ",
                    "offsets_in_document": [
                        {
                            "start": 937,
                            "end": 950
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 69,
                            "end": 82
                        }
                    ],
                    "document_id": "b34e39cb7bbc81437c8ffd482817981b",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 2,
                        "page": 1,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "LAA occlusion",
                    "type": "extractive",
                    "score": 0.8391476273536682,
                    "context": "cation, many centers, including our own, began using this device for LAA occlusion. Lakkireddy et al. (4) have reported the largest compilation of cli",
                    "offsets_in_document": [
                        {
                            "start": 501,
                            "end": 514
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 69,
                            "end": 82
                        }
                    ],
                    "document_id": "79aa89c62cd88005e3f977d3e7458d25",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 1,
                        "page": 1,
                        "name": "Lariat_device.pdf"
                    }
                },
                {
                    "answer": "clinical practice",
                    "type": "extractive",
                    "score": 0.7990031838417053,
                    "context": "ssified based on different indications than what it is used for in clinical practice, it may carry an inappropriate class II designation of “intermedi",
                    "offsets_in_document": [
                        {
                            "start": 675,
                            "end": 692
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 84
                        }
                    ],
                    "document_id": "c1de2bf29904d27b0e37c64dcfb164ce",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 17,
                        "page": 4,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "routine LAA occlusion",
                    "type": "extractive",
                    "score": 0.7641706466674805,
                    "context": "aid Services in the ﬁrst national coverage determination led most centers in the United States to abandon the use of Lariat for routine LAA occlusion.",
                    "offsets_in_document": [
                        {
                            "start": 1199,
                            "end": 1220
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 128,
                            "end": 149
                        }
                    ],
                    "document_id": "79aa89c62cd88005e3f977d3e7458d25",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 1,
                        "page": 1,
                        "name": "Lariat_device.pdf"
                    }
                },
                {
                    "answer": "stroke prevention",
                    "type": "extractive",
                    "score": 0.7058628797531128,
                    "context": "Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Card",
                    "offsets_in_document": [
                        {
                            "start": 62,
                            "end": 79
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 62,
                            "end": 79
                        }
                    ],
                    "document_id": "6d47408ec7f5b09ec573bfe4cc9ff018",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 36,
                        "page": 6,
                        "name": "Lariat1.pdf"
                    }
                }
            ]
        },
        {
            "query": "What are contraindications for this device?",
            "answers": [
                {
                    "answer": "anticoagulant therapy",
                    "type": "extractive",
                    "score": 0.9055479764938354,
                    "context": "nts who are at high risk of stroke and have contraindications to anticoagulant therapy that the newer procedures and techniques prove to be safe and e",
                    "offsets_in_document": [
                        {
                            "start": 567,
                            "end": 588
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 65,
                            "end": 86
                        }
                    ],
                    "document_id": "d92d48d72e332306313a59fbd65246c6",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 27,
                        "page": 5,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "OAC therapy",
                    "type": "extractive",
                    "score": 0.7217686176300049,
                    "context": "tion for preventing strokes in patients who have contraindications to OAC therapy. The main difficulty in performing the LARIAT procedure is the need ",
                    "offsets_in_document": [
                        {
                            "start": 512,
                            "end": 523
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 70,
                            "end": 81
                        }
                    ],
                    "document_id": "45e9a4af9b0545dccd26e1a89eda6ab9",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 19,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7212554135949243,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "oral anticoagulant therapy",
                    "type": "extractive",
                    "score": 0.7204751968383789,
                    "context": "event AF-related stroke in patients with contraindications to oral anticoagulant therapy. J Teh Univ Heart Ctr 2015;10(2):69-73 This paper should be c",
                    "offsets_in_document": [
                        {
                            "start": 199,
                            "end": 225
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 62,
                            "end": 88
                        }
                    ],
                    "document_id": "59027053271741269b0a388f0f7a10f3",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 1,
                        "page": 1,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "oral anticoagulant therapy",
                    "type": "extractive",
                    "score": 0.6898214817047119,
                    "context": " the LAA closure with the LARIAT Suture Delivery Device to prevent AF-related stroke in patients with contraindications to oral anticoagulant therapy.",
                    "offsets_in_document": [
                        {
                            "start": 1221,
                            "end": 1247
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 123,
                            "end": 149
                        }
                    ],
                    "document_id": "710eb296b85c4bab7fc4140c7e13dc43",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 0,
                        "page": 1,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                }
            ]
        },
        {
            "query": "Who should not use this device?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7976668044088469,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "major cardiology professional organizations",
                    "type": "extractive",
                    "score": 0.10425382852554321,
                    "context": "w studies. This technique is yet to be adapted by the major cardiology professional organizations into the clinical guidelines for the management of A",
                    "offsets_in_document": [
                        {
                            "start": 1153,
                            "end": 1196
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 54,
                            "end": 97
                        }
                    ],
                    "document_id": "d92d48d72e332306313a59fbd65246c6",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 27,
                        "page": 5,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "patients",
                    "type": "extractive",
                    "score": 0.06922583281993866,
                    "context": "the therapeutic range.18 Furthermore, Warfarin use is inconvenient for patients because it requires conitnuous INR monitoring and dose adjustments and",
                    "offsets_in_document": [
                        {
                            "start": 243,
                            "end": 251
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 71,
                            "end": 79
                        }
                    ],
                    "document_id": "29c02f5524893f9ebc5af87a07576e03",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 18,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "medical community",
                    "type": "extractive",
                    "score": 0.03443346917629242,
                    "context": "d clinical trials examining the Lariat as a device for LAA exclusion should be obtained before its widespread use is adopted by the medical community.",
                    "offsets_in_document": [
                        {
                            "start": 1380,
                            "end": 1397
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 132,
                            "end": 149
                        }
                    ],
                    "document_id": "a08210a119b3b2b2234e9adc1895337d",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 28,
                        "page": 5,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "FDA MAUDE database have not been independently verified, and the actual incidence of adverse events with the Lariat device in general practice cannot be calculated because the denominator of procedures performed remains unknown. We did not compare the Lariat device with other devices or procedures. We did not assess publication bias. We also did not control for operator-related or companion device–related factors. Because our analysis is based on published reports and case reports, we cannot say to what extent the Lariat device is being used for its cleared indications",
                    "type": "extractive",
                    "score": 0.013732509687542915,
                    "context": " FDA MAUDE database have not been independently verified, and the actual incidence of adverse events with the Lariat device in general practice cannot be calculated because the denominator of procedures performed remains unknown. We did not compare the Lariat device with other devices or procedures. We did not assess publication bias. We also did not control for operator-related or companion device–related factors. Because our analysis is based on published reports and case reports, we cannot say to what extent the Lariat device is being used for its cleared indications",
                    "offsets_in_document": [
                        {
                            "start": 391,
                            "end": 966
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 1,
                            "end": 576
                        }
                    ],
                    "document_id": "a08210a119b3b2b2234e9adc1895337d",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 28,
                        "page": 5,
                        "name": "Lariat1.pdf"
                    }
                }
            ]
        },
        {
            "query": "What are the dimensions of the device?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.7365747423437103,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "13-Fr",
                    "type": "extractive",
                    "score": 0.6244393587112427,
                    "context": "and 0.035-inch opposite-pole, magnettipped guide wires (FindrWIRZ); 3) a 13-Fr epicardial guide cannula (SofTIP); and 4) a 12-Fr suture delivery devic",
                    "offsets_in_document": [
                        {
                            "start": 542,
                            "end": 547
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 78
                        }
                    ],
                    "document_id": "ef17dcfb8cdc8341ab82481be36fe3a7",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 8,
                        "page": 2,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "AFhavea5-foldincreasedincidenceofembolicstroke",
                    "type": "extractive",
                    "score": 0.3079046607017517,
                    "context": "million people in the United States.1 Patients with AFhavea5-foldincreasedincidenceofembolicstroke,2 the risk of which has traditionally been managed ",
                    "offsets_in_document": [
                        {
                            "start": 119,
                            "end": 165
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 52,
                            "end": 98
                        }
                    ],
                    "document_id": "925daaa24756e529db5b80fd67490308",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 5,
                        "page": 2,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "0.025-inch and 0.035-inch",
                    "type": "extractive",
                    "score": 0.27715983986854553,
                    "context": "r balloon catheter compatible with 9-Fr access (Endo CATH); 2) 0.025-inch and 0.035-inch opposite-pole, magnettipped guide wires (FindrWIRZ); 3) a 13-",
                    "offsets_in_document": [
                        {
                            "start": 458,
                            "end": 483
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 63,
                            "end": 88
                        }
                    ],
                    "document_id": "ef17dcfb8cdc8341ab82481be36fe3a7",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 8,
                        "page": 2,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "forminimallyinvasiveLAAclosureaftercompletionoftwopivotal",
                    "type": "extractive",
                    "score": 0.2193523347377777,
                    "context": "d the Watchman device (Boston Scientific Corp) forminimallyinvasiveLAAclosureaftercompletionoftwopivotal randomized clinical trials designed to demons",
                    "offsets_in_document": [
                        {
                            "start": 1098,
                            "end": 1155
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 47,
                            "end": 104
                        }
                    ],
                    "document_id": "925daaa24756e529db5b80fd67490308",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 5,
                        "page": 2,
                        "name": "Lariat1.pdf"
                    }
                }
            ]
        },
        {
            "query": "What has this device been approved for?",
            "answers": [
                {
                    "answer": "transcatheter LAA exclusion in patients with atrial fibrillation",
                    "type": "extractive",
                    "score": 0.8096986413002014,
                    "context": "soft tissue.14 This device has been adopted for transcatheter LAA exclusion in patients with atrial fibrillation through a unique epicardial approach.",
                    "offsets_in_document": [
                        {
                            "start": 1848,
                            "end": 1912
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 48,
                            "end": 112
                        }
                    ],
                    "document_id": "93230e53a21fe6797725216a79d57a5d",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 4,
                        "page": 1,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "transcatheter LAA exclusion in patients with atrial fibrillation",
                    "type": "extractive",
                    "score": 0.795326292514801,
                    "context": "tissue.14 This device has been adopted for transcatheter LAA exclusion in patients with atrial fibrillation through a unique epicardial approach. Howe",
                    "offsets_in_document": [
                        {
                            "start": 1571,
                            "end": 1635
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 43,
                            "end": 107
                        }
                    ],
                    "document_id": "925daaa24756e529db5b80fd67490308",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 5,
                        "page": 2,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "transcatheter LAA exclusion in patients with atrial fibrillation",
                    "type": "extractive",
                    "score": 0.7809158563613892,
                    "context": "tissue.14 This device has been adopted for transcatheter LAA exclusion in patients with atrial fibrillation through a unique epicardial approach. Howe",
                    "offsets_in_document": [
                        {
                            "start": 1571,
                            "end": 1635
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 43,
                            "end": 107
                        }
                    ],
                    "document_id": "3ff37e7ff2e5b1fc24c671ac659c0422",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 6,
                        "page": 2,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.5811371775397027,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "long-term stroke prevention",
                    "type": "extractive",
                    "score": 0.47975748777389526,
                    "context": "f the PREVAIL trial raised substantial concerns about the Watchman’s effectiveness for long-term stroke prevention,31 the FDA has approved the device.",
                    "offsets_in_document": [
                        {
                            "start": 760,
                            "end": 787
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 87,
                            "end": 114
                        }
                    ],
                    "document_id": "1406af24da3c805076dc4ca6bcdc792",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 24,
                        "page": 5,
                        "name": "Lariat1.pdf"
                    }
                }
            ]
        },
        {
            "query": "Is the procedure minimally invasive?",
            "answers": [
                {
                    "answer": "LARIAT is a novel, minimally invasive endo-epicardial LAA exclusion technique",
                    "type": "extractive",
                    "score": 0.8221146464347839,
                    "context": "ve been developed for LAA exclusion. LARIAT is a novel, minimally invasive endo-epicardial LAA exclusion technique and in this review article we discu",
                    "offsets_in_document": [
                        {
                            "start": 410,
                            "end": 487
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 37,
                            "end": 114
                        }
                    ],
                    "document_id": "d9df72dd0cfe9ba3eedf23f4d9200b4d",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 0,
                        "page": 1,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "This is a minimally invasive procedure",
                    "type": "extractive",
                    "score": 0.8202265501022339,
                    "context": "This is a minimally invasive procedure and therefore the patients can recover faster from the procedure compared to other surgical or mini thoracotomy",
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 38
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 38
                        }
                    ],
                    "document_id": "4d6607929bbf34f67c802b6b2ebf7105",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 19,
                        "page": 4,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "This is a minimally invasive procedure",
                    "type": "extractive",
                    "score": 0.6880220770835876,
                    "context": "ith contraindications to anticoagulation. Advantages 1. This is a minimally invasive procedure and therefore the patients can recover faster from the ",
                    "offsets_in_document": [
                        {
                            "start": 909,
                            "end": 947
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 56,
                            "end": 94
                        }
                    ],
                    "document_id": "f14585eaba246f4f2d186e245ae67c7d",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 18,
                        "page": 3,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "minimally invasive LAA closure clearly reduces long-term stroke rates in patients with atrial fibrillation is contentious",
                    "type": "extractive",
                    "score": 0.6630842685699463,
                    "context": "assertion that minimally invasive LAA closure clearly reduces long-term stroke rates in patients with atrial fibrillation is contentious. There was in",
                    "offsets_in_document": [
                        {
                            "start": 185,
                            "end": 306
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 15,
                            "end": 136
                        }
                    ],
                    "document_id": "1406af24da3c805076dc4ca6bcdc792",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 24,
                        "page": 5,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "minimally invasive",
                    "type": "extractive",
                    "score": 0.6112544536590576,
                    "context": "The minimally invasive strategies for occluding the LAA ostium include implantation of a foreign body (such as the WATCHMAN Left Atrial Appendage Clos",
                    "offsets_in_document": [
                        {
                            "start": 4,
                            "end": 22
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 4,
                            "end": 22
                        }
                    ],
                    "document_id": "45e9a4af9b0545dccd26e1a89eda6ab9",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 19,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                }
            ]
        },
        {
            "query": "What anesthesia does the procedure require?",
            "answers": [
                {
                    "answer": "general",
                    "type": "extractive",
                    "score": 0.8326265811920166,
                    "context": "a 5) SureCUT ™ suture cutter Technique The procedure is performed under general anesthesia and in a hybrid suite with cardiothoracic surgical backup. ",
                    "offsets_in_document": [
                        {
                            "start": 1093,
                            "end": 1100
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 72,
                            "end": 79
                        }
                    ],
                    "document_id": "dfb9bd6134e8b1cb28eab36799284526",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 8,
                        "page": 2,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "general",
                    "type": "extractive",
                    "score": 0.8176525831222534,
                    "context": "a 5) SureCUT ™ suture cutter Technique The procedure is performed under general anesthesia and in a hybrid suite with cardiothoracic surgical backup. ",
                    "offsets_in_document": [
                        {
                            "start": 387,
                            "end": 394
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 72,
                            "end": 79
                        }
                    ],
                    "document_id": "bb68a0089e6cbf252495f9a96e402137",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 9,
                        "page": 2,
                        "name": "State_of_the_art_lariat.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.715711278708096,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "general",
                    "type": "extractive",
                    "score": 0.6809254884719849,
                    "context": "site-pole, magnet-tipped guide wires (FindrWIRZ) with the patient under general anesthesia. The device consists of four main components: 1) a 15-mm– d",
                    "offsets_in_document": [
                        {
                            "start": 311,
                            "end": 318
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 72,
                            "end": 79
                        }
                    ],
                    "document_id": "ef17dcfb8cdc8341ab82481be36fe3a7",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 8,
                        "page": 2,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "general",
                    "type": "extractive",
                    "score": 0.6100468635559082,
                    "context": "mplanted by electrophysiologists and interventional cardiologists under general anesthesia with transesophageal echocardiography (TEE) guidance. The p",
                    "offsets_in_document": [
                        {
                            "start": 1143,
                            "end": 1150
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 72,
                            "end": 79
                        }
                    ],
                    "document_id": "a0ec7063bb5e05574bc38deea46e4d4c",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 8,
                        "page": 2,
                        "name": "Review_of_lariat.pdf"
                    }
                }
            ]
        },
        {
            "query": "When can patients stop taking blood thinners?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.8463287733696699,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "surgery or during significant bleeding events",
                    "type": "extractive",
                    "score": 0.011640464887022972,
                    "context": "mes when Warfarin should be stopped, for example for surgery or during significant bleeding events, patients with AF are at significant risk of having",
                    "offsets_in_document": [
                        {
                            "start": 677,
                            "end": 722
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 53,
                            "end": 98
                        }
                    ],
                    "document_id": "b0d59110a1f09c25747366c620c66e42",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 17,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "LAA closure therapy",
                    "type": "extractive",
                    "score": 0.004341139458119869,
                    "context": " and hormone levels are changed during the follow-up period after LAA closure therapy. However, the lower systolic and diastolic blood pressure observ",
                    "offsets_in_document": [
                        {
                            "start": 640,
                            "end": 659
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 66,
                            "end": 85
                        }
                    ],
                    "document_id": "693529646be18b504b29d4ff3d729e5f",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 39,
                        "page": 8,
                        "name": "Long_term_effect_on_systemic_hemostasis.pdf"
                    }
                },
                {
                    "answer": "during routine open heart surgery",
                    "type": "extractive",
                    "score": 0.0029634677339345217,
                    "context": "l may be launched. Nowhere would this be more logical than during routine open heart surgery. LAA exclusion can be done directly with minimal increase",
                    "offsets_in_document": [
                        {
                            "start": 983,
                            "end": 1016
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 59,
                            "end": 92
                        }
                    ],
                    "document_id": "8639f9f8593fc3b6d957575e2d91118b",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 8,
                        "page": 2,
                        "name": "Lariat_device.pdf"
                    }
                },
                {
                    "answer": "acute bleeding event",
                    "type": "extractive",
                    "score": 0.002005285117775202,
                    "context": "se and inability to expeditiously reverse these agents during an acute bleeding event (Connolly et al. 2009; Patel et al. 2011; Granger et al. 2011). ",
                    "offsets_in_document": [
                        {
                            "start": 536,
                            "end": 556
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 65,
                            "end": 85
                        }
                    ],
                    "document_id": "fc1f3bcc8cbcd0e792ecf3cdd00fb785",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 3,
                        "page": 1,
                        "name": "Review_of_lariat.pdf"
                    }
                }
            ]
        },
        {
            "query": "When can patients stop taking anticoagulants?",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.8187931690777304,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "cannot be used in patients who are at high risk for bleeding events",
                    "type": "extractive",
                    "score": 0.15091224014759064,
                    "context": "gulants increase the risk of bleeding and cannot be used in patients who are at high risk for bleeding events. Because thrombi formed in the LAA cause",
                    "offsets_in_document": [
                        {
                            "start": 504,
                            "end": 571
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 42,
                            "end": 109
                        }
                    ],
                    "document_id": "29c02f5524893f9ebc5af87a07576e03",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 18,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "for surgery or during significant bleeding events",
                    "type": "extractive",
                    "score": 0.10535646975040436,
                    "context": "times when Warfarin should be stopped, for example for surgery or during significant bleeding events, patients with AF are at significant risk of havi",
                    "offsets_in_document": [
                        {
                            "start": 673,
                            "end": 722
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 51,
                            "end": 100
                        }
                    ],
                    "document_id": "b0d59110a1f09c25747366c620c66e42",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 17,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "May 26, 2014. 11",
                    "type": "extractive",
                    "score": 0.002628228161484003,
                    "context": "ryCommittee /CirculatorySystemDevicesPanel/UCM377356.pdf. Accessed May 26, 2014. 11. Hornung M, Bertog SC, Franke J, et al. Long-term results of a ran",
                    "offsets_in_document": [
                        {
                            "start": 1097,
                            "end": 1113
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 83
                        }
                    ],
                    "document_id": "de39a25433c2e78a058dba4642f70e75",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 32,
                        "page": 6,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "lack of antidotes",
                    "type": "extractive",
                    "score": 0.002347223926335573,
                    "context": "oenterology. 2013;145(1):105-112.e15. 7. Wallace H, Davies MW. The lack of antidotes for new oral anticoagulants. BMJ. 2014;348:g1438. 8. Manning WJ. ",
                    "offsets_in_document": [
                        {
                            "start": 253,
                            "end": 270
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 67,
                            "end": 84
                        }
                    ],
                    "document_id": "de39a25433c2e78a058dba4642f70e75",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 32,
                        "page": 6,
                        "name": "Lariat1.pdf"
                    }
                }
            ]
        },
        {
            "query": "What is the success rate of the procedure?",
            "answers": [
                {
                    "answer": "> 90%",
                    "type": "extractive",
                    "score": 0.9640605449676514,
                    "context": "acceptable acute success rate of the LAA closure with the LARIAT device (> 90%) and the relatively low rate of complications associated with this proc",
                    "offsets_in_document": [
                        {
                            "start": 288,
                            "end": 293
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 78
                        }
                    ],
                    "document_id": "45e9a4af9b0545dccd26e1a89eda6ab9",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 19,
                        "page": 4,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "95%",
                    "type": "extractive",
                    "score": 0.9008044004440308,
                    "context": " these studies, the acute success rate of the LARIAT procedure was around 95%. Follow-up transesophageal echocardiography (TEE) showed a 100% LAA clos",
                    "offsets_in_document": [
                        {
                            "start": 835,
                            "end": 838
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 74,
                            "end": 77
                        }
                    ],
                    "document_id": "ace546e8311bd35bda8d0a09904c0662",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 12,
                        "page": 3,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                },
                {
                    "answer": "90.3%",
                    "type": "extractive",
                    "score": 0.8677674531936646,
                    "context": "LAA closure. Our systematic review revealed a procedural success rate of 90.3% but a potentially concerning safety profile with 1 in-hospital death an",
                    "offsets_in_document": [
                        {
                            "start": 276,
                            "end": 281
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 78
                        }
                    ],
                    "document_id": "d17f3d9eeccf97aa002e877e671017f3",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 16,
                        "page": 4,
                        "name": "Lariat1.pdf"
                    }
                },
                {
                    "answer": "94 %",
                    "type": "extractive",
                    "score": 0.7850567102432251,
                    "context": "ed as device deployment with <5 mm residual leak by TEE, was achieved in 94 % of patients. Major bleeding occurred in 9 % of patients, and peri-proced",
                    "offsets_in_document": [
                        {
                            "start": 419,
                            "end": 423
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 77
                        }
                    ],
                    "document_id": "3e0d6741b32bbf287402b7cab0dbf889",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 32,
                        "page": 9,
                        "name": "Review_of_lariat.pdf"
                    }
                },
                {
                    "answer": "82 (95%",
                    "type": "extractive",
                    "score": 0.6326850652694702,
                    "context": "ntent-to-treat 85 (96%) 20 (95%) 25 (93%) 154 (100%) Procedural success 82 (95%) 19 (95%) 25 (93%) 132 (86%) Time to follow-up TEE 1 y 96 ± 77 d* 45 ±",
                    "offsets_in_document": [
                        {
                            "start": 584,
                            "end": 591
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 72,
                            "end": 79
                        }
                    ],
                    "document_id": "637694de12c5580db9525b127e7f1c38",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 14,
                        "page": 3,
                        "name": "Review_of_LARIAT_Suture_Delivery.pdf"
                    }
                }
            ]
        },
        {
            "query": "What is the occurrence of pericardial effusions?",
            "answers": [
                {
                    "answer": "Late",
                    "type": "extractive",
                    "score": 0.7183722257614136,
                    "context": "icardial access for expedited drainage of a large effusion (Price 2014). Late pericardial effusions may develop and are hypothesized to result from in",
                    "offsets_in_document": [
                        {
                            "start": 728,
                            "end": 732
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 73,
                            "end": 77
                        }
                    ],
                    "document_id": "4c4da8e6c4a4e3a768d5a8cc556f276",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 15,
                        "page": 4,
                        "name": "Review_of_lariat.pdf"
                    }
                },
                {
                    "answer": "5",
                    "type": "extractive",
                    "score": 0.6400120258331299,
                    "context": "ion), 13 pericardial effusions, 7 pericarditis, 4 pleural effusions 1 CVA, 5 pericardial effusions, 2 pericarditis, 2 pleural effusions 127 ± 50 NR TE",
                    "offsets_in_document": [
                        {
                            "start": 322,
                            "end": 323
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 75,
                            "end": 76
                        }
                    ],
                    "document_id": "4d8dadae3a1959188d8dd0a6682877c9",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 31,
                        "page": 8,
                        "name": "Review_of_lariat.pdf"
                    }
                },
                {
                    "answer": "16",
                    "type": "extractive",
                    "score": 0.5988796949386597,
                    "context": "perforation), 1 patient death due to nosocomial pneumonia post-procedure, 16 pericardial effusions, 4 pleural effusions At a mean of 112 days follow-u",
                    "offsets_in_document": [
                        {
                            "start": 844,
                            "end": 846
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 74,
                            "end": 76
                        }
                    ],
                    "document_id": "ec48df6c46357dbeedf689639e12e1ed",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 29,
                        "page": 8,
                        "name": "Review_of_lariat.pdf"
                    }
                },
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.5768528357054824,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "5",
                    "type": "extractive",
                    "score": 0.5333974361419678,
                    "context": "ion), 13 pericardial effusions, 7 pericarditis, 4 pleural effusions 1 CVA, 5 pericardial effusions, 2 pericarditis, 2 pleural effusions 127 ± 50 NR TE",
                    "offsets_in_document": [
                        {
                            "start": 808,
                            "end": 809
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 75,
                            "end": 76
                        }
                    ],
                    "document_id": "7555c78c4aff922b7cf9dba9f01f2df",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 30,
                        "page": 8,
                        "name": "Review_of_lariat.pdf"
                    }
                }
            ]
        },
        {
            "query": "Trying to get no answer",
            "answers": [
                {
                    "answer": "",
                    "type": "extractive",
                    "score": 0.6870677676793354,
                    "context": null,
                    "offsets_in_document": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 0,
                            "end": 0
                        }
                    ],
                    "document_id": null,
                    "meta": {}
                },
                {
                    "answer": "no AC 3.2 ± 1.2/4.8 ± 1.3 3.5 ± 1.0",
                    "type": "extractive",
                    "score": 0.14961741864681244,
                    "context": "pyridamole, 15 % on warfarin, 5 % on rivaroxaban, 20 % on no AC 3.2 ± 1.2/4.8 ± 1.3 3.5 ± 1.0 Stone et al. (2013) 27 42 screened, 15 excluded; no furt",
                    "offsets_in_document": [
                        {
                            "start": 478,
                            "end": 513
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 58,
                            "end": 93
                        }
                    ],
                    "document_id": "93ac4504693de381746019f52c95e5da",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 22,
                        "page": 6,
                        "name": "Review_of_lariat.pdf"
                    }
                },
                {
                    "answer": "- no change",
                    "type": "extractive",
                    "score": 0.07815618813037872,
                    "context": " ↓ ↓ Endothelin ↑ ↑ ↑ ↑ ↑ ↑ ↑ All values compared to baseline levels, - no change, ↑ increased level, ↓ decreased level. NT-proBNP: The mean baseline ",
                    "offsets_in_document": [
                        {
                            "start": 317,
                            "end": 328
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 70,
                            "end": 81
                        }
                    ],
                    "document_id": "6ed73e386fc919c51f34e7264fbbb264",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 22,
                        "page": 5,
                        "name": "Long_term_effect_on_systemic_hemostasis.pdf"
                    }
                },
                {
                    "answer": "there was no signiﬁcant difference in sodium at subsequent time intervals",
                    "type": "extractive",
                    "score": 0.07052499055862427,
                    "context": " 2.6 mmol/L; p value < 0.05). However, there was no signiﬁcant difference in sodium at subsequent time intervals. There were also no signiﬁcant change",
                    "offsets_in_document": [
                        {
                            "start": 856,
                            "end": 929
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 39,
                            "end": 112
                        }
                    ],
                    "document_id": "cdf1853f98a1f02fe38f2297ec2dbe68",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 12,
                        "name": "Long_term_effect_on_systemic_hemostasis.pdf"
                    }
                },
                {
                    "answer": "there was no signiﬁcant difference in sodium at subsequent time intervals",
                    "type": "extractive",
                    "score": 0.07052499055862427,
                    "context": " 2.6 mmol/L; p value < 0.05). However, there was no signiﬁcant difference in sodium at subsequent time intervals. There were also no signiﬁcant change",
                    "offsets_in_document": [
                        {
                            "start": 856,
                            "end": 929
                        }
                    ],
                    "offsets_in_context": [
                        {
                            "start": 39,
                            "end": 112
                        }
                    ],
                    "document_id": "1ac3dc42e734ea9683bbc359e9dd84ec",
                    "meta": {
                        "device": "Lariat",
                        "_split_id": 12,
                        "page": 3,
                        "name": "Long_term_effect_on_systemic_hemostasis.pdf"
                    }
                }
            ]
        }
    ]
}